{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:29:31Z","timestamp":1788560971860,"version":"build-2803163510"},"reference-count":251,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Traumatic brain injury and Alzheimer\u2019s disease share pathological similarities, including neuronal loss, amyloid-\u03b2 deposition, tau hyperphosphorylation, blood\u2013brain barrier dysfunction, neuroinflammation, and cognitive deficits. Furthermore, traumatic brain injury can exacerbate Alzheimer\u2019s disease-like pathologies, potentially leading to the development of Alzheimer\u2019s disease. Nanocarriers offer a potential solution by facilitating the delivery of small interfering RNAs across the blood\u2013brain barrier for the targeted silencing of key pathological genes implicated in traumatic brain injury and Alzheimer\u2019s disease. Unlike traditional approaches to neuroregeneration, this is a molecular-targeted strategy, thus avoiding non-specific drug actions. This review focuses on the use of nanocarrier systems for the efficient and precise delivery of siRNAs, discussing the advantages, challenges, and future directions. In principle, siRNAs have the potential to target all genes and non-targetable proteins, holding significant promise for treating various diseases. Among the various therapeutic approaches currently available for neurological diseases, siRNA gene silencing can precisely \u201cturn off\u201d the expression of any gene at the genetic level, thus radically inhibiting disease progression; however, a significant challenge lies in delivering siRNAs across the blood\u2013brain barrier. Nanoparticles have received increasing attention as an innovative drug delivery tool for the treatment of brain diseases. They are considered a potential therapeutic strategy with the advantages of being able to cross the blood\u2013brain barrier, targeted drug delivery, enhanced drug stability, and multifunctional therapy. The use of nanoparticles to deliver specific modified siRNAs to the injured brain is gradually being recognized as a feasible and effective approach. Although this strategy is still in the preclinical exploration stage, it is expected to achieve clinical translation in the future, creating a new field of molecular targeted therapy and precision medicine for the treatment of Alzheimer\u2019s disease associated with traumatic brain injury.<\/jats:p>","DOI":"10.4103\/nrr.nrr-d-24-00303","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T04:03:21Z","timestamp":1727150601000},"page":"2538-2555","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Nanocarrier-mediated siRNA delivery: a new approach for the treatment of traumatic brain injury\u2013related Alzheimer\u2019s disease"],"prefix":"10.4103","volume":"20","author":[{"given":"Jie","family":"Jin","sequence":"first","affiliation":[{"name":"Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China"},{"name":"Key Laboratory for Disaster Medicine Technology, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianying","family":"Lu","sequence":"additional","affiliation":[{"name":"Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China"},{"name":"Key Laboratory for Disaster Medicine Technology, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqiang","family":"Tian","sequence":"additional","affiliation":[{"name":"Henan Medical Key Laboratory for Research of Trauma and Orthopedics, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan Province, China"},{"name":"Clinical Medical Center of Tissue Engineering and Regeneration, Xinxiang Medical University, Xinxiang, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanqiao","family":"Yao","sequence":"additional","affiliation":[{"name":"Institutes of Health Central Plain, Xinxiang Medical University, Xinxiang, Henan Province, China"},{"name":"School of Public Health, Xinxiang Medical University, Xinxiang, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lai","sequence":"additional","affiliation":[{"name":"Henan Medical Key Laboratory for Research of Trauma and Orthopedics, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Liang","sequence":"additional","affiliation":[{"name":"Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanchuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Lu","sequence":"additional","affiliation":[{"name":"Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Tian","sequence":"additional","affiliation":[{"name":"Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8572-6470","authenticated-orcid":false,"given":"Yanmei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China"},{"name":"Key Laboratory for Disaster Medicine Technology, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4711-2352","authenticated-orcid":false,"given":"Wenjie","family":"Ren","sequence":"additional","affiliation":[{"name":"Henan Medical Key Laboratory for Research of Trauma and Orthopedics, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan Province, China"},{"name":"Clinical Medical Center of Tissue Engineering and Regeneration, Xinxiang Medical University, Xinxiang, Henan Province, China"},{"name":"Institutes of Health Central Plain, Xinxiang Medical University, Xinxiang, Henan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"key":"R1-20260427","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1038\/s41467-023-39857-9","article-title":"V\u03b31 and V\u03b34 gamma-delta T cells play opposing roles in the immunopathology of traumatic brain injury in males","volume":"14","author":"Abou-El-Hassan","year":"2023","journal-title":"Nat Commun"},{"key":"R2-20260427","doi-asserted-by":"crossref","first-page":"113257","DOI":"10.1016\/j.expneurol.2020.113257","article-title":"Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia","volume":"328","author":"Abrahamson","year":"2020","journal-title":"Exp Neurol"},{"key":"R3-20260427","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/bpa.12532","article-title":"Rapid amyloid\u2010\u03b2 oligomer and protofibril accumulation in traumatic brain injury","volume":"28","author":"Abu Hamdeh","year":"2018","journal-title":"Brain Pathol"},{"key":"R4-20260427","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.4103\/1673-5374.386406","article-title":"Amyloid-beta and tau protein beyond Alzheimer\u2019s disease","volume":"19","author":"Abyadeh","year":"2024","journal-title":"Neural Regen Res"},{"key":"R5-20260427","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s12276-023-00998-y","article-title":"Where should siRNAs go: applicable organs for siRNA drugs","volume":"55","author":"Ahn","year":"2023","journal-title":"Exp Mol Med"},{"key":"R6-20260427","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat Biotechnol"},{"key":"R7-20260427","doi-asserted-by":"crossref","first-page":"2002944","DOI":"10.1002\/advs.202002944","article-title":"Mesenchymal stem cells for neurological disorders","volume":"8","author":"Andrzejewska","year":"2021","journal-title":"Adv Sci"},{"key":"R8-20260427","doi-asserted-by":"crossref","first-page":"e10143","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng transl med"},{"key":"R9-20260427","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae-The first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Control Release"},{"key":"R10-20260427","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s44161-021-00014-4","article-title":"Blood\u2013brain barrier link to human cognitive impairment and Alzheimer\u2019s disease","volume":"1","author":"Barisano","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"R11-20260427","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jconrel.2022.06.011","article-title":"Recent progresses in exosome-based systems for targeted drug delivery to the brain","volume":"348","author":"Bashyal","year":"2022","journal-title":"J Control Release"},{"key":"R12-20260427","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/nano10071403","article-title":"Polymeric nanoparticles for drug delivery: recent developments and future prospects","volume":"10","author":"Begines","year":"2020","journal-title":"Nanomaterials (Basel)"},{"key":"R13-20260427","doi-asserted-by":"crossref","first-page":"e0185943","DOI":"10.1371\/journal.pone.0185943","article-title":"Effects of AAV-mediated knockdown of nNOS and GPx-1 gene expression in rat hippocampus after traumatic brain injury","volume":"12","author":"Boone","year":"2017","journal-title":"PLoS One"},{"key":"R14-20260427","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2021.05.025","article-title":"Traumatic brain injury and risk of neurodegenerative disorder","volume":"91","author":"Brett","year":"2022","journal-title":"Biol Psychiatry"},{"key":"R15-20260427","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"R16-20260427","first-page":"56","article-title":"ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT\/NF\u03baB\/NLRP3 pathway","volume":"20","author":"Cai","year":"2022","journal-title":"Cell Commun"},{"key":"R17-20260427","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/jfb10010004","article-title":"Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies","volume":"10","author":"Calzoni","year":"2019","journal-title":"J Funct Biomater"},{"key":"R18-20260427","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3233\/JAD-170669","article-title":"Dementia pugilistica revisited","volume":"60","author":"Castellani","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"key":"R19-20260427","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4103\/1673-5374.380874","article-title":"Neural stem cells promote neuroplasticity: a promising therapeutic strategy for the treatment of Alzheimer\u2019s disease","volume":"19","author":"Chang","year":"2024","journal-title":"Neural Regen Res"},{"key":"R20-20260427","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4103\/1673-5374.347740","article-title":"Proteomics of serum exosomes identified fibulin-1 as a novel biomarker for mild cognitive impairment","volume":"18","author":"Chen","year":"2023","journal-title":"Neural Regen Res"},{"key":"R21-20260427","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.bbi.2020.03.022","article-title":"5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer\u2019s disease","volume":"88","author":"Chen","year":"2020","journal-title":"Brain Behav Immun"},{"key":"R22-20260427","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneumeth.2016.06.018","article-title":"Neuroinflammation in animal models of traumatic brain injury","volume":"272","author":"Chiu","year":"2016","journal-title":"J Neurosci Methods"},{"issue":"Suppl 9","key":"R23-20260427","first-page":"S98","article-title":"Amyloid and tau\u2010PET in early\u2010onset AD: baseline data from the longitudinal early-onset Alzheimer\u2019s disease study (LEADS)","volume":"19","author":"Cho","year":"2023","journal-title":"Alzheimers Dement"},{"key":"R24-20260427","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/1673-5374.374137","article-title":"Biomaterials-based anti-inflammatory treatment strategies for Alzheimer\u2019s disease","volume":"19","author":"Chu","year":"2024","journal-title":"Neural Regen Res"},{"key":"R25-20260427","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/acsami.2c17802","article-title":"Iron oxide nanoparticles decorated with functional peptides for a targeted siRNA delivery to glioma cells","volume":"15","author":"Chung","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"R26-20260427","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1111\/bph.14471","article-title":"Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, \u03b1\u2010synuclein, amyloid\u2010\u03b2 and insulin resistance in neurodegenerative diseases","volume":"175","author":"Clark","year":"2018","journal-title":"Br J Pharmacol"},{"key":"R27-20260427","first-page":"789","article-title":"Hopping the hurdle: strategies to enhance the molecular delivery to the brain through the Blood\u2013Brain Barrier","volume":"13","author":"Cogill","year":"2024","journal-title":"Cells (Basel)"},{"key":"R28-20260427","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/antiox10050818","article-title":"Hidrox\u00ae roles in neuroprotection: biochemical links between traumatic brain injury and alzheimer\u2019s disease","volume":"10","author":"Cordaro","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"R29-20260427","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.pa.34.040194.000441","article-title":"beta-Amyloid formation as a potential therapeutic target for Alzheimer\u2019s disease","volume":"34","author":"Cordell","year":"1994","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R30-20260427","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1089\/ars.2012.4981","article-title":"Traumatic brain injury: oxidative stress and neuroprotection","volume":"19","author":"Cornelius","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"R31-20260427","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/106002809402800612","article-title":"Tacrine: first drug approved for Alzheimer\u2019s disease","volume":"28","author":"Crismon","year":"1994","journal-title":"Ann Pharmacother"},{"key":"R32-20260427","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol Ther"},{"key":"R33-20260427","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/d41573-020-00220-y","article-title":"Exosome-based candidates move into the clinic","volume":"20","author":"Cully","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"R34-20260427","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jnnp.2003.033126","article-title":"Monitoring and interpretation of intracranial pressure","volume":"75","author":"Czosnyka","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R35-20260427","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/WAD.0000000000000607","article-title":"Interaction of Alzheimer disease and traumatic brain injury on cortical thickness","volume":"38","author":"D\u2019Souza","year":"2024","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R36-20260427","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/cid\/ciz325","article-title":"Elevated cerebrospinal fluid tau protein concentrations on admission are associated with long-term neurologic and cognitive impairment in Ugandan children with cerebral malaria","volume":"70","author":"Datta","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R37-20260427","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fneur.2019.00198","article-title":"Cognitive impairment following acute mild traumatic brain injury","volume":"10","author":"de Freitas Cardoso","year":"2019","journal-title":"Front Neurol"},{"key":"R38-20260427","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/ACO.0000000000001183","article-title":"Cerebral metabolic derangements following traumatic brain injury","volume":"35","author":"Demers-Marcil","year":"2022","journal-title":"Curr Opin Anaesthesiol"},{"key":"R39-20260427","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","article-title":"Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease","volume":"29","author":"Dhapola","year":"2021","journal-title":"Inflammopharmacology"},{"key":"R40-20260427","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13195-023-01238-1","article-title":"Avoiding future controversies in the Alzheimer\u2019s disease space through understanding the aducanumab data and FDA review","volume":"15","author":"Dickson","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"R41-20260427","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3233\/JAD-231198","article-title":"Substantial doubt remains about the efficacy of anti-amyloid antibodies","volume":"97","author":"Digma","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"R42-20260427","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mattod.2020.02.001","article-title":"Overcoming blood\u2013brain barrier transport: advances in nanoparticle-based drug delivery strategies","volume":"37","author":"Ding","year":"2020","journal-title":"Mater Today"},{"key":"R43-20260427","first-page":"1","article-title":"A\u03b21\u20136A2V (D) peptide, effective on A\u03b2 aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury","author":"Diomede","year":"2023","journal-title":"Mol Psychiatry"},{"key":"R44-20260427","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-019-02004-0","article-title":"The new genetic landscape of Alzheimer\u2019s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?","volume":"138","author":"Dourlen","year":"2019","journal-title":"Acta Neuropathol"},{"key":"R45-20260427","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1038\/s41380-022-01711-7","article-title":"A novel circular RNA, circIgfbp2, links neural plasticity and anxiety through targeting mitochondrial dysfunction and oxidative stress-induced synapse dysfunction after traumatic brain injury","volume":"27","author":"Du","year":"2022","journal-title":"Mol Psychiatry"},{"key":"R46-20260427","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/neu.2018.6348","article-title":"Traumatic brain injury induces tau aggregation and spreading","volume":"37","author":"Edwards","year":"2020","journal-title":"J Neurotrauma"},{"key":"R47-20260427","doi-asserted-by":"crossref","first-page":"zsx212","DOI":"10.1093\/sleep\/zsx212","article-title":"Dietary therapy restores glutamatergic input to orexin\/hypocretin neurons after traumatic brain injury in mice","volume":"41","author":"Elliott","year":"2018","journal-title":"Sleep"},{"key":"R48-20260427","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.phrs.2017.03.020","article-title":"Nanotechnological strategies for nerve growth factor delivery: therapeutic implications in Alzheimer\u2019s disease","volume":"120","author":"Faustino","year":"2017","journal-title":"Pharmacol Res"},{"key":"R49-20260427","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1007\/s12035-021-02324-x","article-title":"Stem cell-derived exosomes: a new strategy of neurodegenerative disease treatment","volume":"58","author":"Fayazi","year":"2021","journal-title":"Mol Neurobiol"},{"key":"R50-20260427","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.4103\/1673-5374.389362","article-title":"Ferroptosis mechanism and Alzheimer\u2019s disease","volume":"19","author":"Feng","year":"2024","journal-title":"Neural Regen Res"},{"key":"R51-20260427","doi-asserted-by":"crossref","first-page":"e2017337","DOI":"10.1001\/jamanetworkopen.2020.17337","article-title":"Effect of transcranial low-level light therapy vs sham therapy among patients with moderate traumatic brain injury: a randomized clinical trial","volume":"3","author":"Figueiro Longo","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R52-20260427","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","article-title":"Recent advancements in liposome technology","volume":"156","author":"Filipczak","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"R53-20260427","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1002\/anie.200701979","article-title":"Gene silencing by double\u2010stranded RNA (Nobel lecture)","volume":"46","author":"Fire","year":"2007","journal-title":"Angew Chem Int Ed"},{"key":"R54-20260427","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1038\/s41467-021-23762-0","article-title":"Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer\u2019s disease","volume":"12","author":"Fitz","year":"2021","journal-title":"Nat Commun"},{"key":"R55-20260427","doi-asserted-by":"crossref","first-page":"428010","DOI":"10.1155\/2012\/428010","article-title":"Mechanism of oxidative stress in neurodegeneration","volume":"2012","author":"Gandhi","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"R56-20260427","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-022-02449-w","article-title":"TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury","volume":"144","author":"Gao","year":"2022","journal-title":"Acta Neuropathol"},{"key":"R57-20260427","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s11095-013-1122-4","article-title":"Targeted delivery of nano-therapeutics for major disorders of the central nervous system","volume":"30","author":"Gao","year":"2013","journal-title":"Pharm Res"},{"key":"R58-20260427","doi-asserted-by":"crossref","first-page":"136310","DOI":"10.1016\/j.cej.2022.136310","article-title":"Development of in silico methodology for siRNA lipid nanoparticle formulations","volume":"442","author":"Gao","year":"2022","journal-title":"Chem Eng J"},{"key":"R59-20260427","first-page":"4164","article-title":"Establishment of a rat model of traumatic brain injury using the modified Feeney\u2019s free-fall method","volume":"28","author":"Gao","year":"2024","journal-title":"Zhongguo Zuzhi Gongcheng Yanjiu"},{"key":"R60-20260427","doi-asserted-by":"crossref","first-page":"e24566","DOI":"10.1371\/journal.pone.0024566","article-title":"Moderate traumatic brain injury causes acute dendritic and synaptic degeneration in the hippocampal dentate gyrus","volume":"6","author":"Gao","year":"2011","journal-title":"PLoS One"},{"key":"R62-20260427","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/NRE-182618","article-title":"Cognitive impairment and health-related quality of life following traumatic brain injury","volume":"44","author":"Gorgoraptis","year":"2019","journal-title":"NeuroRehabilitation"},{"key":"R63-20260427","doi-asserted-by":"crossref","first-page":"eaaw1993","DOI":"10.1126\/scitranslmed.aaw1993","article-title":"In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury","volume":"11","author":"Gorgoraptis","year":"2019","journal-title":"Sci Transl Med"},{"key":"R64-20260427","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/brain\/awaa316","article-title":"Diffuse axonal injury predicts neurodegeneration after moderate\u2013severe traumatic brain injury","volume":"143","author":"Graham","year":"2020","journal-title":"Brain"},{"key":"R65-20260427","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1002\/alz.12934","article-title":"Distinct patterns of neurodegeneration after TBI and in Alzheimer\u2019s disease","volume":"19","author":"Graham","year":"2023","journal-title":"Alzheimers Dement"},{"key":"R66-20260427","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3389\/fnins.2020.00894","article-title":"The bidirectional relationship between sleep and inflammation links traumatic brain injury and Alzheimer\u2019s disease","volume":"14","author":"Green","year":"2020","journal-title":"Front Neurosci"},{"key":"R67-20260427","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.apsb.2018.12.010","article-title":"Small interfering RNA delivery to the neurons near the amyloid plaques for improved treatment of Alzheimer\u05f3 s disease","volume":"9","author":"Guo","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"R68-20260427","doi-asserted-by":"crossref","first-page":"10015","DOI":"10.1021\/acsnano.9b01892","article-title":"Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury","volume":"13","author":"Guo","year":"2019","journal-title":"ACS Nano"},{"key":"R69-20260427","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1021\/acsami.1c22434","article-title":"Specific silencing of microglial gene expression in the rat brain by nanoparticle-based small interfering RNA delivery","volume":"14","author":"Guo","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"R70-20260427","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"R71-20260427","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1002\/mco2.410","article-title":"The emerging role of exosomes in communication between the periphery and the central nervous system","volume":"4","author":"Han","year":"2023","journal-title":"MedComm"},{"key":"R72-20260427","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41401-020-0429-z","article-title":"Nanomedicine-based immunotherapy for central nervous system disorders","volume":"41","author":"Hanif","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"R73-20260427","doi-asserted-by":"crossref","first-page":"e143777","DOI":"10.1172\/JCI143777","article-title":"Brain-gut axis dysfunction in the pathogenesis of traumatic brain injury","volume":"131","author":"Hanscom","year":"2021","journal-title":"J Clin Investig"},{"key":"R74-20260427","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J Cell Biol"},{"key":"R75-20260427","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease:the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"R76-20260427","first-page":"e12070","article-title":"Toward refining Alzheimer\u2019s disease into overlapping subgroups","volume":"6","author":"Hascup","year":"2020","journal-title":"Alzheimers Dement"},{"key":"R77-20260427","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1038\/s41467-022-31776-5","article-title":"Disruption of tubulin-alpha4a polyglutamylation prevents aggregation of hyper-phosphorylated tau and microglia activation in mice","volume":"13","author":"Hausrat","year":"2022","journal-title":"Nat Commun"},{"key":"R78-20260427","doi-asserted-by":"crossref","first-page":"102848","DOI":"10.1016\/j.redox.2023.102848","article-title":"Protective effects of luteolin against amyloid beta-induced oxidative stress and mitochondrial impairments through peroxisome proliferator-activated receptor \u03b3-dependent mechanism in Alzheimer\u2019s disease","volume":"66","author":"He","year":"2023","journal-title":"Redox Biol"},{"key":"R79-20260427","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnmol.2017.00022","article-title":"APP as a protective factor in acute neuronal insults","volume":"10","author":"Hefter","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"R80-20260427","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-med-051022-043645","article-title":"Lessons learned from approval of aducanumab for Alzheimer\u2019s disease","volume":"75","author":"Heidebrink","year":"2024","journal-title":"Annu Rev Med"},{"key":"R81-20260427","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1093\/brain\/awab255","article-title":"Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury","volume":"144","author":"Hermanides","year":"2021","journal-title":"Brain"},{"key":"R82-20260427","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tins.2016.03.002","article-title":"Traumatic axonal injury:mechanisms and translational opportunities","volume":"39","author":"Hill","year":"2016","journal-title":"Trends Neurosci"},{"key":"R83-20260427","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Sig Transduct Target Ther"},{"key":"R84-20260427","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41467-023-35868-8","article-title":"Near-infrared-IIb emitting single-atom catalyst for imaging-guided therapy of blood-brain barrier breakdown after traumatic brain injury","volume":"14","author":"Huang","year":"2023","journal-title":"Nat Commun"},{"key":"R85-20260427","doi-asserted-by":"crossref","first-page":"0180","DOI":"10.34133\/research.0180","article-title":"Pathological BBB crossing melanin-like nanoparticles as metal-ion chelator and neuroinflammation regulator against Alzheimer\u2019s disease","volume":"6","author":"Huang","year":"2023","journal-title":"Research"},{"key":"R86-20260427","doi-asserted-by":"crossref","first-page":"100857","DOI":"10.1016\/j.yfrne.2020.100857","article-title":"Blood-brain barrier integrity in the pathogenesis of Alzheimer\u2019s disease","volume":"59","author":"Huang","year":"2020","journal-title":"Front Neuroendocrinol"},{"key":"R87-20260427","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awaa321","article-title":"The synapse in traumatic brain injury","volume":"144","author":"Jamjoom","year":"2021","journal-title":"Brain"},{"key":"R88-20260427","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-04009-7","article-title":"Mitochondrial transportation, transplantation, and subsequent immune response in Alzheimer\u2019s disease: an update","author":"Javadpour","year":"2024","journal-title":"Mol Neurobiol"},{"key":"R89-20260427","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuropharm.2018.08.004","article-title":"Pathophysiology and treatment of cerebral edema in traumatic brain injury","volume":"145","author":"Jha","year":"2019","journal-title":"Neuropharmacology"},{"key":"R90-20260427","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/NRR.NRR-D-23-01201","article-title":"Repetitive transcranial magnetic stimulation in Alzheimer\u2019s disease: effects on neural and synaptic rehabilitation","volume":"20","author":"Ji","year":"2024","journal-title":"Neural Regen Res"},{"key":"R91-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00665-8","article-title":"Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytes","volume":"18","author":"Jiang","year":"2020","journal-title":"J Nanobiotechnology"},{"key":"R92-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2022.08.014","article-title":"Inflammasome activation in traumatic brain injury and Alzheimer\u2019s disease","volume":"254","author":"Johnson","year":"2023","journal-title":"Transl Res"},{"key":"R93-20260427","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.trsl.2023.02.001","article-title":"Genetic predisposition to Alzheimer\u2019s disease alters inflammasome activity after traumatic brain injury","volume":"257","author":"Johnson","year":"2023","journal-title":"Transl Res"},{"key":"R94-20260427","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrn2808","article-title":"Traumatic brain injury and amyloid-\u03b2 pathology: a link to Alzheimer\u2019s disease?","volume":"11","author":"Johnson","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"R95-20260427","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.rehab.2017.03.009","article-title":"Association of traumatic brain injury and Alzheimer disease onset: a systematic review","volume":"60","author":"Julien","year":"2017","journal-title":"Ann Phys Rehabil Med"},{"key":"R96-20260427","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.18632\/aging.205541","article-title":"Orexin-A alleviates ferroptosis by activating the Nrf2\/HO-1 signaling pathway in traumatic brain injury","volume":"16","author":"Kang","year":"2024","journal-title":"Aging"},{"key":"R97-20260427","doi-asserted-by":"crossref","first-page":"118278","DOI":"10.1016\/j.molliq.2021.118278","article-title":"Efficiency of lipid-based nano drug delivery systems in crossing the blood\u2013brain barrier: a review","volume":"346","author":"Khaledian","year":"2022","journal-title":"J Mol Liq"},{"key":"R98-20260427","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1208\/s12248-021-00653-2","article-title":"Development of lipidoid nanoparticles for siRNA delivery to neural cells","volume":"24","author":"Khare","year":"2021","journal-title":"AAPS J"},{"key":"R99-20260427","doi-asserted-by":"crossref","first-page":"114861","DOI":"10.1016\/j.addr.2023.114861","article-title":"Lipid nanoparticle-mediated drug delivery to the brain","volume":"197","author":"Khare","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"R100-20260427","doi-asserted-by":"crossref","first-page":"1903637","DOI":"10.1002\/adma.201903637","article-title":"Rekindling RNAi therapy:materials design requirements for in vivo siRNA delivery","volume":"31","author":"Kim","year":"2019","journal-title":"Adv Mater"},{"key":"R101-20260427","first-page":"497","article-title":"Potential Alzheimer\u2019s disease therapeutic nano-platform: Discovery of amyloid-beta plaque disaggregating agent and brain-targeted delivery system using porous silicon nanoparticles","volume":"24","author":"Kim","year":"2023","journal-title":"Bioact Mater"},{"key":"R102-20260427","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s12276-022-00757-5","article-title":"RNA therapy: rich history, various applications and unlimited future prospects","volume":"54","author":"Kim","year":"2022","journal-title":"Exp Mol Med"},{"key":"R103-20260427","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fimmu.2018.00672","article-title":"The inflammatory continuum of traumatic brain injury and Alzheimer\u2019s disease","volume":"9","author":"Kokiko-Cochran","year":"2018","journal-title":"Front Immunol"},{"key":"R104-20260427","doi-asserted-by":"crossref","first-page":"110961","DOI":"10.1016\/j.forsciint.2021.110961","article-title":"Expression of orexin-A (hypocretin-A) in the hypothalamus after traumatic brain injury: a postmortem evaluation","volume":"327","author":"Kousi","year":"2021","journal-title":"Forensic Sci Int"},{"key":"R105-20260427","doi-asserted-by":"crossref","first-page":"21733","DOI":"10.1039\/C9NR09347H","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","volume":"11","author":"Kulkarni","year":"2019","journal-title":"Nanoscale"},{"key":"R106-20260427","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","article-title":"Lipid nanoparticle technology for clinical translation of siRNA therapeutics","volume":"52","author":"Kulkarni","year":"2019","journal-title":"Acc Chem Res"},{"key":"R107-20260427","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.bbi.2012.06.008","article-title":"Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention","volume":"26","author":"Kumar","year":"2012","journal-title":"Brain Behav Immun"},{"key":"R108-20260427","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1021\/acsnano.6b03858","article-title":"Neuron-targeted nanoparticle for siRNA delivery to traumatic brain injuries","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"key":"R109-20260427","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders:the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener"},{"key":"R110-20260427","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tem.2022.04.003","article-title":"Metabolic disorders on cognitive dysfunction after traumatic brain injury","volume":"33","author":"Lai","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"R111-20260427","doi-asserted-by":"crossref","first-page":"113307","DOI":"10.1016\/j.expneurol.2020.113307","article-title":"Mitochondrial damage & lipid signaling in traumatic brain injury","volume":"329","author":"Lamade","year":"2020","journal-title":"Exp Neurol"},{"key":"R112-20260427","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamaneurol.2023.1081","article-title":"Tau pathology without A\u03b2\u2014A limited PART of clinical progression","volume":"80","author":"Landau","year":"2023","journal-title":"JAMA Neurol"},{"key":"R113-20260427","doi-asserted-by":"crossref","first-page":"111647","DOI":"10.1016\/j.eurpolymj.2022.111647","article-title":"Multi-functional Fe3O4@ HMPDA@ G5-Au core-releasable satellite nano drug carriers for multimodal treatment of tumor cells","volume":"181","author":"Li","year":"2022","journal-title":"Eur Polym J"},{"key":"R114-20260427","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neubiorev.2020.10.020","article-title":"An update on the association between traumatic brain injury and Alzheimer\u2019s disease:Focus on Tau pathology and synaptic dysfunction","volume":"120","author":"Li","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"R115-20260427","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1389201020666190924164152","article-title":"Lipid-based vehicles for siRNA delivery in biomedical field","volume":"21","author":"Li","year":"2020","journal-title":"Curr Pharm Biotechnol"},{"key":"R116-20260427","doi-asserted-by":"crossref","first-page":"eabd6889","DOI":"10.1126\/sciadv.abd6889","article-title":"BBB pathophysiology\u2013independent delivery of siRNA in traumatic brain injury","volume":"7","author":"Li","year":"2021","journal-title":"Sci Adv"},{"key":"R117-20260427","doi-asserted-by":"crossref","first-page":"110887","DOI":"10.1016\/j.biopha.2020.110887","article-title":"Melatonin regulates A\u03b2 production\/clearance balance and A\u03b2 neurotoxicity: a potential therapeutic molecule for Alzheimer\u2019s disease","volume":"132","author":"Li","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"R118-20260427","doi-asserted-by":"crossref","first-page":"101006","DOI":"10.1016\/j.nantod.2020.101006","article-title":"Strategies and materials of\u201d SMART\u201d non-viral vectors:Overcoming the barriers for brain gene therapy","volume":"35","author":"Li","year":"2020","journal-title":"Nano Today"},{"key":"R119-20260427","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2019.04.004","article-title":"Neuronanotechnology for brain regeneration","volume":"148","author":"Liaw","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"R120-20260427","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.mito.2004.07.021","article-title":"Mitochondrial damage and dysfunction in traumatic brain injury","volume":"4","author":"Lifshitz","year":"2004","journal-title":"Mitochondrion"},{"key":"R121-20260427","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2147\/IJN.S450853","article-title":"Nanoparticle-based combinational strategies for overcoming the blood\u2013brain barrier and blood-tumor barrier","author":"Lim","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"R122-20260427","doi-asserted-by":"crossref","first-page":"121645","DOI":"10.1016\/j.biomaterials.2022.121645","article-title":"An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy","volume":"287","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"key":"R123-20260427","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.cclet.2021.03.015","article-title":"Challenges in cell membrane-camouflaged drug delivery systems:Development strategies and future prospects","volume":"32","author":"Liu","year":"2021","journal-title":"Chin Chem Lett"},{"key":"R124-20260427","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/1673-5374.344829","article-title":"Maraviroc promotes recovery from traumatic brain injury in mice by suppression of neuroinflammation and activation of neurotoxic reactive astrocytes","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen Res"},{"key":"R125-20260427","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/svn-2022-002009","article-title":"Penumbra-targeted CircOGDH siRNA-loaded nanoparticles alleviate neuronal apoptosis in focal brain ischaemia","volume":"9","author":"Liu","year":"2023","journal-title":"Stroke Vasc Neurol"},{"key":"R126-20260427","doi-asserted-by":"crossref","first-page":"46290","DOI":"10.1021\/acsami.2c13129","article-title":"Dendrimer\u2013siRNA conjugates for targeted intracellular delivery in glioblastoma animal models","volume":"14","author":"Liyanage","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"key":"R127-20260427","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-022-01298-z","article-title":"Nucleic acid drug vectors for diagnosis and treatment of brain diseases","volume":"8","author":"Lu","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"R128-20260427","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3390\/pharmaceutics13081193","article-title":"Emerging nano-carrier strategies for brain tumor drug delivery and considerations for clinical translation","volume":"13","author":"Lundy","year":"2021","journal-title":"Pharmaceutics"},{"key":"R129-20260427","doi-asserted-by":"crossref","first-page":"2201740","DOI":"10.1002\/advs.202201740","article-title":"Delivering the promise of gene therapy with nanomedicines in treating central nervous system diseases","volume":"9","author":"Luo","year":"2022","journal-title":"Adv Sci"},{"key":"R130-20260427","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41401-020-00503-5","article-title":"Drug development in targeting ion channels for brain edema","volume":"41","author":"Luo","year":"2020","journal-title":"Acta Pharmacologica Sinica"},{"key":"R131-20260427","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.addr.2020.06.020","article-title":"Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles","volume":"156","author":"Luther","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"R132-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2013.10.004","article-title":"Neuroinflammation:the role and consequences","volume":"79","author":"Lyman","year":"2014","journal-title":"Neurosci Res"},{"key":"R133-20260427","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IJN.S384343","article-title":"Inorganic nanoparticles-based systems in biomedical applications of stem cells: opportunities and challenges","author":"Ma","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"R134-20260427","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","article-title":"Traumatic brain injury: progress and challenges in prevention, clinical care, and research","volume":"21","author":"Maas","year":"2022","journal-title":"Lancet Neurol"},{"key":"R135-20260427","doi-asserted-by":"crossref","first-page":"102343","DOI":"10.1016\/j.nano.2020.102343","article-title":"Local delivery of RhoA siRNA by PgP nanocarrier reduces inflammatory response and improves neuronal cell survival in a rat TBI model","volume":"32","author":"Macks","year":"2021","journal-title":"Nanomedicine (Lond)"},{"key":"R136-20260427","doi-asserted-by":"crossref","first-page":"401","DOI":"10.18433\/J3CP55","article-title":"Liposomal drug delivery: a versatile platform for challenging clinical applications","volume":"17","author":"Madni","year":"2014","journal-title":"J Pharm Pharm Sci"},{"key":"R137-20260427","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.addr.2019.07.010","article-title":"Nanocarrier-based systems for targeted and site specific therapeutic delivery","volume":"144","author":"Majumder","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"R138-20260427","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/joim.12900","article-title":"Treatments and rehabilitation in the acute and chronic state of traumatic brain injury","volume":"285","author":"Marklund","year":"2019","journal-title":"J Intern Med"},{"key":"R139-20260427","doi-asserted-by":"crossref","first-page":"24386","DOI":"10.1039\/D0RA04599C","article-title":"Luminescent chitosan\/carbon dots as an effective nano-drug carrier for neurodegenerative diseases","volume":"10","author":"Mathew","year":"2020","journal-title":"Rsc Adv"},{"key":"R140-20260427","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jddst.2017.09.022","article-title":"Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders","volume":"43","author":"Md","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"R141-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-015-2868-x","article-title":"Titanium oxide (TiO 2) nanoparticles in induction of apoptosis and inflammatory response in brain","volume":"17","author":"Meena","year":"2015","journal-title":"J Nanopart Res"},{"key":"R142-20260427","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1021\/acs.molpharmaceut.0c01238","article-title":"Advances in the design of (nano) formulations for delivery of antisense oligonucleotides and small interfering RNA:Focus on the central nervous system","volume":"18","author":"Mendon\u00e7a","year":"2021","journal-title":"Mol Pharm"},{"key":"R143-20260427","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1039\/D1TB02015C","article-title":"Influence of nanoparticle size on blood\u2013brain barrier penetration and the accumulation of anti-seizure medicines in the brain","volume":"10","author":"Meng","year":"2022","journal-title":"J Mater Chem B"},{"key":"R144-20260427","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/28.suppl_B.83","article-title":"Liposomal amphotericin B (AmBisome): safety data from a phase II\/III clinical trial","volume":"28","author":"Meunier","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"R145-20260427","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.3390\/ijms22126418","article-title":"Pathophysiological responses and roles of astrocytes in traumatic brain injury","volume":"22","author":"Michinaga","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R146-20260427","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/neu.2020.7228","article-title":"Differences between men and women in treatment and outcome after traumatic brain injury","volume":"38","author":"Mikoli\u0107","year":"2021","journal-title":"J Neurotrauma"},{"key":"R147-20260427","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1089\/neu.2019.6534","article-title":"Non-invasive transcranial nano-pulsed laser therapy ameliorates cognitive function and prevents aberrant migration of neural progenitor cells in the hippocampus of rats subjected to traumatic brain injury","volume":"37","author":"Mocciaro","year":"2020","journal-title":"J Neurotrauma"},{"key":"R148-20260427","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00415-021-10669-5","article-title":"Traumatic brain injury fast-forwards Alzheimer\u2019s pathology: evidence from amyloid positron emission tomorgraphy imaging","volume":"269","author":"Mohamed","year":"2022","journal-title":"J Neurol"},{"key":"R149-20260427","doi-asserted-by":"crossref","first-page":"15185","DOI":"10.1038\/s41598-021-94175-8","article-title":"Dopamine-loaded nanoparticle systems circumvent the blood\u2013brain barrier restoring motor function in mouse model for Parkinson\u2019s Disease","volume":"11","author":"Monge-Fuentes","year":"2021","journal-title":"Sci Rep"},{"key":"R150-20260427","doi-asserted-by":"crossref","first-page":"15185","DOI":"10.1038\/s41598-021-94175-8","article-title":"Dopamine-loaded nanoparticle systems circumvent the blood-brain barrier restoring motor function in mouse model for Parkinson\u2019s Disease","volume":"11","author":"Monge-Fuentes","year":"2021","journal-title":"Sci Rep"},{"key":"R151-20260427","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-024-07132-6","article-title":"Multisensory gamma stimulation promotes glymphatic clearance of amyloid","volume":"627","author":"Murdock","year":"2024","journal-title":"Nature"},{"key":"R152-20260427","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fncel.2019.00528","article-title":"Traumatic brain injuries:pathophysiology and potential therapeutic targets","volume":"13","author":"Ng","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"R153-20260427","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-04035-5","article-title":"Traumatic brain injury in mice generates early-stage Alzheimer\u2019s disease related protein pathology that correlates with neurobehavioral deficits","author":"Panayi","year":"2024","journal-title":"Mol Neurobiol"},{"key":"R154-20260427","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejpb.2021.02.010","article-title":"Recent update of toxicity aspects of nanoparticulate systems for drug delivery","volume":"161","author":"Patnaik","year":"2021","journal-title":"Eur J Pharm Biopharm"},{"key":"R155-20260427","doi-asserted-by":"crossref","first-page":"2201095","DOI":"10.1002\/adma.202201095","article-title":"Anionic lipid nanoparticles preferentially deliver mRNA to the hepatic reticuloendothelial system","volume":"34","author":"Pattipeiluhu","year":"2022","journal-title":"Adv Mater"},{"key":"R156-20260427","doi-asserted-by":"crossref","first-page":"107102","DOI":"10.1016\/j.phrs.2024.107102","article-title":"Nanoparticles and siRNA: a new era in therapeutics?","volume":"201","author":"P\u00e9rez-Carri\u00f3n","year":"2024","journal-title":"Pharmacol Res"},{"key":"R157-20260427","doi-asserted-by":"crossref","first-page":"371","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of early Alzheimer\u2019s disease:clinical practice in 2021","volume":"8","author":"Porsteinsson","year":"2021","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"R158-20260427","first-page":"1307","article-title":"The pathophysiology of traumatic brain injury at a glance","volume":"6","author":"Prins","year":"2013","journal-title":"Dis Models Mech"},{"key":"R159-20260427","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40263-024-01067-2","article-title":"Comparative efficacy and safety of monoclonal antibodies for cognitive decline in patients with alzheimer\u2019s disease: a systematic review and network meta-analysis","volume":"38","author":"Qiao","year":"2024","journal-title":"CNS Drugs"},{"key":"R160-20260427","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2013.08.005","article-title":"Chitosan-based siRNA delivery systems","volume":"172","author":"Ragelle","year":"2013","journal-title":"J Control Release"},{"key":"R161-20260427","doi-asserted-by":"crossref","first-page":"e2309225","DOI":"10.1002\/adma.202309225","article-title":"Nanoparticle\u2010mediated delivery of Anti\u2010PU. 1 siRNA via localized intracisternal administration reduces neuroinflammation","volume":"36","author":"Ralvenius","year":"2023","journal-title":"Adv Mater"},{"key":"R162-20260427","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ebiom.2018.01.021","article-title":"Traumatic brain injury and Alzheimer\u2019s disease:the cerebrovascular link","volume":"28","author":"Ramos-Cejudo","year":"2018","journal-title":"Ebiomedicine"},{"key":"R163-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease:Pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol Neurodegener"},{"key":"R164-20260427","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s41061-017-0127-6","article-title":"Polymers in the delivery of siRNA for the treatment of virus infections","volume":"375","author":"Reynolds","year":"2017","journal-title":"Top Curr Chem"},{"key":"R165-20260427","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1111\/bph.15488","article-title":"TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury","volume":"178","author":"Rosa","year":"2021","journal-title":"Br J Pharmacol"},{"key":"R166-20260427","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s11357-021-00355-9","article-title":"Acute cognitive impairment after traumatic brain injury predicts the occurrence of brain atrophy patterns similar to those observed in Alzheimer\u2019s disease","volume":"43","author":"Rostowsky","year":"2021","journal-title":"Geroscience"},{"key":"R167-20260427","doi-asserted-by":"crossref","first-page":"114968","DOI":"10.1016\/j.addr.2023.114968","article-title":"siRNA drug delivery across the blood-brain barrier in Alzheimer\u2019s Disease","volume":"199","author":"Sajid","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"R168-20260427","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/medicina56030137","article-title":"Traumatic brain injury and stem cells: an overview of clinical trials, the current treatments and future therapeutic approaches","volume":"56","author":"Schepici","year":"2020","journal-title":"Medicina"},{"key":"R169-20260427","doi-asserted-by":"crossref","first-page":"e1248","DOI":"10.1212\/WNL.0000000000200041","article-title":"Cognitive outcome 1 year after mild traumatic brain injury: results from the TRACK-TBI study","volume":"98","author":"Schneider","year":"2022","journal-title":"Neurology"},{"key":"R170-20260427","doi-asserted-by":"crossref","first-page":"2200353","DOI":"10.1002\/advs.202200353","article-title":"Functionalized macrophage exosomes with panobinostat and PPM1D\u2010siRNA for diffuse intrinsic pontine gliomas therapy","volume":"9","author":"Shan","year":"2022","journal-title":"Adv Sci"},{"key":"R171-20260427","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2020.04.036","article-title":"Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury","volume":"323","author":"Sharma","year":"2020","journal-title":"J Control Release"},{"key":"R172-20260427","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1101\/gad.880001","article-title":"RNA interference-2001","volume":"15","author":"Sharp","year":"2001","journal-title":"Genes Dev"},{"key":"R173-20260427","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1567201818666211213102308","article-title":"Recent approaches and success of liposome-based nano drug carriers for the treatment of brain tumor","volume":"19","author":"Shaw","year":"2022","journal-title":"Curr Drug Deliv"},{"key":"R174-20260427","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41423-019-0213-5","article-title":"Dissemination of brain inflammation in traumatic brain injury","volume":"16","author":"Shi","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"R175-20260427","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-024-00715-x","article-title":"Rejuvenating aged microglia by p16ink4a-siRNA-loaded nanoparticles increases amyloid-\u03b2 clearance in animal models of Alzheimer\u2019s disease","volume":"19","author":"Shin","year":"2024","journal-title":"Mol Neurodegener"},{"key":"R176-20260427","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","article-title":"Reducing acetylated tau is neuroprotective in brain injury","volume":"184","author":"Shin","year":"2021","journal-title":"Cell"},{"key":"R177-20260427","doi-asserted-by":"crossref","first-page":"eabn0441","DOI":"10.1126\/scitranslmed.abn0441","article-title":"Precision functional MRI mapping reveals distinct connectivity patterns for depression associated with traumatic brain injury","volume":"15","author":"Siddiqi","year":"2023","journal-title":"Sci Transl Med"},{"key":"R178-20260427","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"R179-20260427","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/ijms22042153","article-title":"Regenerative stem cell therapy for neurodegenerative diseases: an overview","volume":"22","author":"Sivandzade","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R180-20260427","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1471-4159.2006.04212.x","article-title":"Alois Alzheimer and Alzheimer\u2019s disease: a centennial perspective","volume":"99","author":"Small","year":"2006","journal-title":"J Neurochem"},{"key":"R181-20260427","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, aducanumab, and gantenerumab-binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease","volume":"20","author":"S\u00f6derberg","year":"2023","journal-title":"Neurotherapeutics"},{"key":"R182-20260427","doi-asserted-by":"crossref","first-page":"793253","DOI":"10.3389\/fneur.2022.793253","article-title":"Transcranial magnetic stimulation in the treatment of neurological diseases","volume":"13","author":"Somaa","year":"2022","journal-title":"Front Neurol"},{"key":"R183-20260427","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0166-2236(98)01337-X","article-title":"Tau protein pathology in neurodegenerative diseases","volume":"21","author":"Spillantini","year":"1998","journal-title":"Trends Neurosci"},{"key":"R184-20260427","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.3390\/ijms22094595","article-title":"Inorganic nanoparticles and composite films for antimicrobial therapies","volume":"22","author":"Spirescu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R185-20260427","doi-asserted-by":"crossref","first-page":"113320","DOI":"10.1016\/j.ejmech.2021.113320","article-title":"Alzheimer\u2019s disease and its treatment by different approaches: a review","volume":"216","author":"Srivastava","year":"2021","journal-title":"Eur J Med Chem"},{"key":"R186-20260427","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.2009.06531.x","article-title":"Initial calcium release from intracellular stores followed by calcium dysregulation is linked to secondary axotomy following transient axonal stretch injury","volume":"112","author":"Staal","year":"2010","journal-title":"J Neurochem"},{"key":"R187-20260427","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.actbio.2021.12.023","article-title":"Targeted delivery of PARP inhibitors to neuronal mitochondria via biomimetic engineered nanosystems in a mouse model of traumatic brain injury","volume":"140","author":"Sun","year":"2022","journal-title":"Acta Biomater"},{"key":"R188-20260427","doi-asserted-by":"crossref","first-page":"106153","DOI":"10.1016\/j.phrs.2022.106153","article-title":"miR-30a-5p induces A\u03b2 production via inhibiting the nonamyloidogenic pathway in Alzheimer\u2019s disease","volume":"178","author":"Sun","year":"2022","journal-title":"Pharmacol Res"},{"key":"R189-20260427","doi-asserted-by":"crossref","first-page":"100397","DOI":"10.1016\/j.nanoso.2019.100397","article-title":"Recent developments in functionalized polymer nanoparticles for efficient drug delivery system","volume":"20","author":"Sur","year":"2019","journal-title":"Nano-Struct Nano-Objects"},{"key":"R190-20260427","doi-asserted-by":"crossref","first-page":"e78851","DOI":"10.1371\/journal.pone.0078851","article-title":"Traumatic brain injury precipitates cognitive impairment and extracellular A\u03b2 aggregation in Alzheimer\u2019s disease transgenic mice","volume":"8","author":"Tajiri","year":"2013","journal-title":"PLoS One"},{"key":"R191-20260427","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jconrel.2022.01.044","article-title":"Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer\u2019s disease","volume":"343","author":"Taliyan","year":"2022","journal-title":"J Control Release"},{"key":"R192-20260427","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.actbio.2022.11.013","article-title":"A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration","volume":"155","author":"Tang","year":"2023","journal-title":"Acta Biomater"},{"key":"R193-20260427","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/ph15070838","article-title":"Current and potential pharmacologic therapies for traumatic brain injury","volume":"15","author":"Tani","year":"2022","journal-title":"Pharmaceuticals"},{"key":"R194-20260427","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","article-title":"Neuronal hyperexcitability in Alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype?","volume":"12","author":"Targa Dias Anastacio","year":"2022","journal-title":"Transl Psychiatry"},{"key":"R195-20260427","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s12031-021-01841-7","article-title":"Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets","volume":"71","author":"Thapa","year":"2021","journal-title":"J Mol Neurosci"},{"key":"R196-20260427","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/brain\/awq353","article-title":"Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients","volume":"134","author":"Timofeev","year":"2011","journal-title":"Brain"},{"key":"R197-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0320-x","article-title":"\u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol Neurodegener"},{"key":"R198-20260427","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.neuroscience.2004.06.046","article-title":"Edema and brain trauma","volume":"129","author":"Unterberg","year":"2004","journal-title":"Neuroscience"},{"key":"R199-20260427","first-page":"1","article-title":"Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease","volume":"11","author":"van der Velpen","year":"2019","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"R200-20260427","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/CIA.S325026","article-title":"Role of aducanumab in the treatment of Alzheimer\u2019s disease:Challenges and opportunities","volume":"17","author":"Vaz","year":"2022","journal-title":"Clin Interv Aging"},{"key":"R201-20260427","doi-asserted-by":"crossref","first-page":"e10248","DOI":"10.15252\/emmm.201810248","article-title":"Inflammasomes in neuroinflammatory and neurodegenerative diseases","volume":"11","author":"Voet","year":"2019","journal-title":"Embo Mol Med"},{"key":"R202-20260427","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1039\/D2BM01846B","article-title":"Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury","volume":"11","author":"Waggoner","year":"2023","journal-title":"Biomater Sci"},{"key":"R203-20260427","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fnagi.2013.00029","article-title":"Molecular mechanisms of cognitive dysfunction following traumatic brain injury","volume":"5","author":"Walker","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"R204-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol Neurodegener"},{"key":"R205-20260427","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/WNL.0000000000006322","article-title":"CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury","volume":"91","author":"Williams","year":"2018","journal-title":"Neurology"},{"key":"R206-20260427","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/cns.13300","article-title":"Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury","volume":"26","author":"Willing","year":"2020","journal-title":"CNS Neurosci Ther"},{"key":"R207-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-02041-7","article-title":"Mer regulates microglial\/macrophage M1\/M2 polarization and alleviates neuroinflammation following traumatic brain injury","volume":"18","author":"Wu","year":"2021","journal-title":"J Neuroinflammation"},{"key":"R208-20260427","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40478-021-01178-7","article-title":"Mild traumatic brain injury induces microvascular injury and accelerates Alzheimer-like pathogenesis in mice","volume":"9","author":"Wu","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"R209-20260427","doi-asserted-by":"crossref","first-page":"101730","DOI":"10.1016\/j.pneurobio.2019.101730","article-title":"Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer\u2019s disease pathology","volume":"185","author":"Wu","year":"2020","journal-title":"Prog Neurobiol"},{"key":"R210-20260427","doi-asserted-by":"crossref","first-page":"102065","DOI":"10.1016\/j.omtn.2023.102065","article-title":"Astrocyte-targeted siRNA delivery by adenosine-functionalized LNP in mouse TBI model","volume":"34","author":"Xiao","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"R211-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.01.036","article-title":"Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy","volume":"105","author":"Xu","year":"2020","journal-title":"Acta Biomater"},{"key":"R212-20260427","doi-asserted-by":"crossref","first-page":"102477","DOI":"10.1016\/j.pneurobio.2023.102477","article-title":"Trigeminal nerve stimulation restores hippocampal dopamine deficiency to promote cognitive recovery in traumatic brain injury","volume":"227","author":"Xu","year":"2023","journal-title":"Prog Neurobiol"},{"key":"R213-20260427","doi-asserted-by":"crossref","first-page":"2100109","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery","volume":"2","author":"Xu","year":"2022","journal-title":"Adv Nanobiomed Res"},{"key":"R214-20260427","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.7150\/thno.62330","article-title":"Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies","volume":"11","author":"Xu","year":"2021","journal-title":"Theranostics"},{"key":"R215-20260427","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cjtee.2020.10.001","article-title":"Glucose metabolism: a link between traumatic brain injury and Alzheimer\u2019s disease","volume":"24","author":"Xu","year":"2021","journal-title":"Chin J Traumatol"},{"key":"R216-20260427","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.msec.2018.05.031","article-title":"Polyester based nanovehicles for siRNA delivery","volume":"92","author":"Xu","year":"2018","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"R217-20260427","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41420-023-01324-1","article-title":"Neuroprotective effect of astragalin via activating PI3K\/Akt-mTOR-mediated autophagy on APP\/PS1 mice","volume":"9","author":"Yang","year":"2023","journal-title":"Cell Death Discovery"},{"key":"R218-20260427","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41590-020-00812-1","article-title":"Neuroinflammation after surgery: from mechanisms to therapeutic targets","volume":"21","author":"Yang","year":"2020","journal-title":"Nat Immunol"},{"key":"R219-20260427","doi-asserted-by":"crossref","first-page":"2203182","DOI":"10.1002\/smll.202203182","article-title":"Intranasal delivery of BACE1 siRNA and rapamycin by dual targets modified nanoparticles for Alzheimer\u2019s disease therapy","volume":"18","author":"Yang","year":"2022","journal-title":"Small"},{"key":"R220-20260427","doi-asserted-by":"crossref","first-page":"100129","DOI":"10.1016\/j.medidd.2022.100129","article-title":"Engineered biomimetic drug-delivery systems for ischemic stroke therapy","volume":"15","author":"Yang","year":"2022","journal-title":"Med Drug Discov"},{"key":"R221-20260427","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jconrel.2021.12.034","article-title":"Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy","volume":"342","author":"Yang","year":"2022","journal-title":"J Control Release"},{"key":"R222-20260427","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4103\/1673-5374.380910","article-title":"P7C3-A20 treats traumatic brain injury in rats by inhibiting excessive autophagy and apoptosis","volume":"19","author":"Yang","year":"2024","journal-title":"Neural Regen Res"},{"key":"R223-20260427","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1089\/neu.2021.0311","article-title":"Combined inhibition of Fyn and c-Src protects hippocampal neurons and improves spatial memory via ROCK after traumatic brain injury","volume":"39","author":"Ye","year":"2022","journal-title":"J Neurotraum"},{"key":"R224-20260427","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-024-05248-x","article-title":"Passive immunotherapy for Alzheimer\u2019s disease: challenges future directions","volume":"22","author":"Yi","year":"2024","journal-title":"J Transl Med"},{"key":"R225-20260427","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2020.07.022","article-title":"Recent advances in siRNA delivery mediated by lipid-based nanoparticles","volume":"154","author":"Yonezawa","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"R226-20260427","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2019.10.039","article-title":"A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease","volume":"315","author":"Yu","year":"2019","journal-title":"J Control Release"},{"key":"R227-20260427","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13619-022-00128-5","article-title":"The therapeutic prospects and challenges of human neural stem cells for the treatment of Alzheimer\u2019s Disease","volume":"11","author":"Yue","year":"2022","journal-title":"Cell Regen"},{"key":"R228-20260427","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nchembio.797","article-title":"Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation","volume":"8","author":"Yuzwa","year":"2012","journal-title":"Nat Chem Biol"},{"key":"R229-20260427","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1039\/C4CS00038B","article-title":"O-GlcNAc and neurodegeneration:biochemical mechanisms and potential roles in Alzheimer\u2019s disease and beyond","volume":"43","author":"Yuzwa","year":"2014","journal-title":"Chem Soc Rev"},{"key":"R230-20260427","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized nanomaterials capable of crossing the blood\u2013brain barrier","volume":"18","author":"Zha","year":"2024","journal-title":"ACS Nano"},{"key":"R231-20260427","doi-asserted-by":"crossref","first-page":"100278","DOI":"10.1016\/j.mtbio.2022.100278","article-title":"In situ forming and biocompatible hyaluronic acid hydrogel with reactive oxygen species-scavenging activity to improve traumatic brain injury repair by suppressing oxidative stress and neuroinflammation","volume":"15","author":"Zhang","year":"2022","journal-title":"Mater Today Bio"},{"key":"R232-20260427","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/NDT.S75546","article-title":"Neuroinflammation in Alzheimer\u2019s disease","author":"Zhang","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R233-20260427","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2015.12.013","article-title":"Targeting specific cells in the brain with nanomedicines for CNS therapies","volume":"240","author":"Zhang","year":"2016","journal-title":"J Control Release"},{"key":"R234-20260427","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/med.21624","article-title":"Advance of sporadic Alzheimer\u2019s disease animal models","volume":"40","author":"Zhang","year":"2020","journal-title":"Med Res Rev"},{"key":"R235-20260427","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/10717544.2021.1934188","article-title":"Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy","volume":"28","author":"Zhang","year":"2021","journal-title":"Drug Deliv"},{"key":"R236-20260427","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.ymthe.2021.10.009","article-title":"sEVsRVG selectively delivers antiviral siRNA to fetus brain, inhibits ZIKV infection and mitigates ZIKV-induced microcephaly in mouse model","volume":"30","author":"Zhang","year":"2022","journal-title":"Mol Ther"},{"key":"R237-20260427","doi-asserted-by":"crossref","first-page":"102089","DOI":"10.1016\/j.pneurobio.2021.102089","article-title":"Glucose metabolic crosstalk and regulation in brain function and diseases","volume":"204","author":"Zhang","year":"2021","journal-title":"Prog Neurobiol"},{"key":"R238-20260427","doi-asserted-by":"crossref","first-page":"2003937","DOI":"10.1002\/advs.202003937","article-title":"Development of polymeric nanoparticles for blood\u2013brain barrier transfer\u2014strategies and challenges","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv Sci"},{"key":"R239-20260427","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/alzrt211","article-title":"The role of APP and BACE1 trafficking in APP processing and amyloid-\u03b2 generation","volume":"5","author":"Zhang","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"R240-20260427","doi-asserted-by":"crossref","first-page":"eadj4260","DOI":"10.1126\/sciadv.adj4260","article-title":"Targeting pyroptosis with nanoparticles to alleviate neuroinflammatory for preventing secondary damage following traumatic brain injury","volume":"10","author":"Zhang","year":"2024","journal-title":"Sci Adv"},{"key":"R241-20260427","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.trsl.2021.03.017","article-title":"Mitochondria transplantation protects traumatic brain injury via promoting neuronal survival and astrocytic BDNF","volume":"235","author":"Zhao","year":"2021","journal-title":"Transl Res"},{"key":"R242-20260427","doi-asserted-by":"crossref","first-page":"101483","DOI":"10.1016\/j.arr.2021.101483","article-title":"Interactions between glial cells and the blood-brain barrier and their role in Alzheimer\u2019s disease","volume":"72","author":"Zhao","year":"2021","journal-title":"Ageing Res Rev"},{"key":"R243-20260427","doi-asserted-by":"crossref","first-page":"eabo6889","DOI":"10.1126\/scitranslmed.abo6889","article-title":"A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury","volume":"15","author":"Zhao","year":"2023","journal-title":"Sci Transl Med"},{"key":"R244-20260427","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.7150\/thno.69465","article-title":"Advances in aptamers against A\u03b2 and applications in A\u03b2 detection and regulation for Alzheimer\u2019s disease","volume":"12","author":"Zheng","year":"2022","journal-title":"Theranostics"},{"key":"R245-20260427","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J Control Release"},{"key":"R246-20260427","first-page":"1","article-title":"Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury","volume":"18","author":"Zhou","year":"2020","journal-title":"Cell Commun"},{"key":"R247-20260427","doi-asserted-by":"crossref","first-page":"eabc7031","DOI":"10.1126\/sciadv.abc7031","article-title":"Blood-brain barrier\u2013penetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy","volume":"6","author":"Zhou","year":"2020","journal-title":"Sci Adv"},{"key":"R248-20260427","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.3390\/molecules25163731","article-title":"Polymeric nanoparticles:production, characterization, toxicology and ecotoxicology","volume":"25","author":"Zieli\u0144ska","year":"2020","journal-title":"Molecules"},{"key":"R249-20260427","doi-asserted-by":"crossref","first-page":"2100722","DOI":"10.1002\/adfm.202100722","article-title":"Biomimetic nanoparticles as a theranostic tool for traumatic brain injury","volume":"31","author":"Zinger","year":"2021","journal-title":"Adv Funct Mater"},{"key":"R250-20260427","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.3390\/molecules25225294","article-title":"Nano carrier drug delivery systems for the treatment of neuropsychiatric disorders: advantages and limitations","volume":"25","author":"Zorkina","year":"2020","journal-title":"Molecules"},{"key":"R251-20260427","doi-asserted-by":"crossref","first-page":"2000416","DOI":"10.1002\/adma.202000416","article-title":"Single siRNA nanocapsules for effective siRNA brain delivery and glioblastoma treatment","volume":"32","author":"Zou","year":"2020","journal-title":"Adv Mater"},{"key":"R252-20260427","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JAD-190572","article-title":"Long-term effects of traumatic brain injury in a mouse model of Alzheimer\u2019s disease","volume":"72","author":"Zy\u015bk","year":"2019","journal-title":"J Alzheimers Dis"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-24-00303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:54:01Z","timestamp":1786647241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/NRR.NRR-D-24-00303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":251,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/nrr.nrr-d-24-00303","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"assertion":[{"value":"2024-03-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}